SCHEMBL545671

SCHEMBL545671

CCO[Ti](O)(O)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.41
CA4 P22748 1/20 0.36
LMNA P02545 1/20 0.35
ALDH1A1 P00352 1/20 0.34
RECQL P46063 1/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
CRHBP P24387 1/20 0.34
RAB9A P51151 1/20 0.34
CRHR2 Q13324 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TSHR P16473 1/20 0.33
MAPT P10636 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
RELA Q04206 1/20 0.33
KCNA3 P22001 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11013365 0.79 LTA4H (0.45) LTA4HCA4LMNAALDH1A1RECQL
SCHEMBL9062579 0.78 LTA4H (0.43) LTA4HCA4LMNATSHRCHRNB2
SCHEMBL20513393 0.75 LTA4H (0.33) LTA4HCA4LMNAALDH1A1RECQL
SCHEMBL10881690 0.73 CA4 (0.42) LTA4HCA4LMNATSHRCHRNB2
SCHEMBL20513460 0.72 LTA4H (0.33) LTA4HCA4LMNAALDH1A1RECQL
SCHEMBL20513560 0.71 CA4 (0.36) LTA4HCA4LMNAALDH1A1RECQL
SCHEMBL20513102 0.71 GLA (0.31) TSHR
SCHEMBL15453496 0.71 LTA4H (0.37) LTA4HCA4ALDH1A1NPC1HPGD
SCHEMBL20513980 0.70 LTA4H (0.39) LTA4HALDH1A1RECQLTSHRMAPT
SCHEMBL14472046 0.69 LTA4H (0.45) LTA4HCA4LMNAALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257520-B1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CATALYTIC DISTILLATION TECH (US) 2018-08-22 EP disclosed
EP-2459511-B1 PROCESS FOR PRODUCING DIPHENYL CARBONATE SHELL INT RESEARCH (NL) 2016-04-27 EP disclosed
US-8569534-B2 Process for producing diphenyl carbonate SHELL OIL COMPANY (US) 2013-10-29 US disclosed
US-8415495-B2 Process for continuous production of organic carbonates or organic carbamates and solid catalysts therefore CATALYTIC DISTILLATION TECHNOLOGIES (US) 2013-04-09 US disclosed
US-8361919-B2 Process for continuous production of organic carbonates or organic carbamates and solid catalysts therefore CATALYTIC DISTILLATION TECHNOLOGIES (US) 2013-01-29 US disclosed
US-20120190878-A1 PROCESS FOR PRODUCING DIPHENYL CARBONATE SHELL OIL COMPANY (US) 2012-07-26 US disclosed
US-8222444-B2 Process for continuous production of organic carbonates or organic carbamates and solid catalysts therefore CATALYTIC DISTILLATION TECHNOLOGIES (US) 2012-07-17 US disclosed
EP-2459511-A2 PROCESS FOR PRODUCING DIPHENYL CARBONATE SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2012-06-06 EP disclosed
US-8110698-B2 Process for producing diphenyl carbonate SHELL OIL COMPANY (US) 2012-02-07 US disclosed
US-20110098499-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2011-04-28 US disclosed
US-20110045965-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2011-02-24 US disclosed
US-20110046409-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2011-02-24 US disclosed
WO-2011014374-A2 PROCESS FOR PRODUCING DIPHENYL CARBONATE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2011-02-03 WO disclosed
US-7851645-B2 Process for continuous production of organic carbonates or organic carbamates and solid catalysts therefore CATALYTIC DISTILLATION TECHNOLOGIES (US) 2010-12-14 US disclosed
EP-2257520-A2 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE Catalytic Distillation Technologies (US) 2010-12-08 EP disclosed
US-20100197952-A1 PROCESS FOR PRODUCING DIPHENYL CARBONATE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2010-08-05 US disclosed
WO-2009102556-A2 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2009-08-20 WO disclosed
US-20090203933-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CATALYTIC DISTILLATION TECHNOLOGIES (US) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197952-A1 PROCESS FOR PRODUCING DIPHENYL CARBONATE CA3, DAGLA, CA2 LTA4H 1748/4885CA4 13/4885LMNA 3412/4885
US-20110046409-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CA14, CA4, ADH1C LTA4H 3165/4885CA4 2/4885LMNA 4644/4885
US-20090203933-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CA14, CA4, ADH1C LTA4H 3165/4885CA4 2/4885LMNA 4644/4885
US-20110098499-A1 PROCESS FOR CONTINUOUS PRODUCTION OF ORGANIC CARBONATES OR ORGANIC CARBAMATES AND SOLID CATALYSTS THEREFORE CA14, CA4, ADH1C LTA4H 3165/4885CA4 2/4885LMNA 4644/4885
US-20120190878-A1 PROCESS FOR PRODUCING DIPHENYL CARBONATE CA3, DAGLA, CA2 LTA4H 1748/4885CA4 13/4885LMNA 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.